Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells

Hui Zheng, Paul Hasty, Mark A. Brenneman, Markus Grompe, Richard A. Gibbs, John H. Wilson, Allan Bradley

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Targeted recombination in murine embryonic stem cells promises to be a powerful tool for introducing specific mutations into target genes to study development in mice and to create animal models of human disease. Gene targeting also holds potential for correcting genetic defects as an approach to human gene therapy. To precisely modify target genes, homologous recombination must proceed with high fidelity. However, several results have suggested that targeted recombination may be highly mutagenic. To test the accuracy of gene targeting we analyzed 44 independent targeted recombinants at the hypoxanthine phosphoribosyltransferase (HPRT) locus in a human fibroblast cell line and in mouse embryonic stem cells. We surveyed 80 kilobases around the sites of recombination by using chemical cleavage of mismatches. Only two mutations were found: a T → G transversion and a thymidine deletion. Thus, gene targeting in mammalian cells can be extremely accurate. These results demonstrate the feasibility of generating precise modifications of mammalian genomes by gene targeting.

Original languageEnglish (US)
Pages (from-to)8067-8071
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume88
Issue number18
StatePublished - 1991
Externally publishedYes

Fingerprint

Gene Targeting
Embryonic Stem Cells
Genetic Recombination
Fibroblasts
Hypoxanthine Phosphoribosyltransferase
Animal Disease Models
Mutation
Homologous Recombination
Genetic Therapy
Thymidine
Genes
Genome
Cell Line

Keywords

  • Chemical cleavage
  • Homologous recombination
  • Hypoxanthine pbosphoribosyltransferase
  • Mutation

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells. / Zheng, Hui; Hasty, Paul; Brenneman, Mark A.; Grompe, Markus; Gibbs, Richard A.; Wilson, John H.; Bradley, Allan.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 88, No. 18, 1991, p. 8067-8071.

Research output: Contribution to journalArticle

Zheng, Hui ; Hasty, Paul ; Brenneman, Mark A. ; Grompe, Markus ; Gibbs, Richard A. ; Wilson, John H. ; Bradley, Allan. / Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells. In: Proceedings of the National Academy of Sciences of the United States of America. 1991 ; Vol. 88, No. 18. pp. 8067-8071.
@article{5824a5e79ba04cf2bb3347fd8128c713,
title = "Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells",
abstract = "Targeted recombination in murine embryonic stem cells promises to be a powerful tool for introducing specific mutations into target genes to study development in mice and to create animal models of human disease. Gene targeting also holds potential for correcting genetic defects as an approach to human gene therapy. To precisely modify target genes, homologous recombination must proceed with high fidelity. However, several results have suggested that targeted recombination may be highly mutagenic. To test the accuracy of gene targeting we analyzed 44 independent targeted recombinants at the hypoxanthine phosphoribosyltransferase (HPRT) locus in a human fibroblast cell line and in mouse embryonic stem cells. We surveyed 80 kilobases around the sites of recombination by using chemical cleavage of mismatches. Only two mutations were found: a T → G transversion and a thymidine deletion. Thus, gene targeting in mammalian cells can be extremely accurate. These results demonstrate the feasibility of generating precise modifications of mammalian genomes by gene targeting.",
keywords = "Chemical cleavage, Homologous recombination, Hypoxanthine pbosphoribosyltransferase, Mutation",
author = "Hui Zheng and Paul Hasty and Brenneman, {Mark A.} and Markus Grompe and Gibbs, {Richard A.} and Wilson, {John H.} and Allan Bradley",
year = "1991",
language = "English (US)",
volume = "88",
pages = "8067--8071",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "18",

}

TY - JOUR

T1 - Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells

AU - Zheng, Hui

AU - Hasty, Paul

AU - Brenneman, Mark A.

AU - Grompe, Markus

AU - Gibbs, Richard A.

AU - Wilson, John H.

AU - Bradley, Allan

PY - 1991

Y1 - 1991

N2 - Targeted recombination in murine embryonic stem cells promises to be a powerful tool for introducing specific mutations into target genes to study development in mice and to create animal models of human disease. Gene targeting also holds potential for correcting genetic defects as an approach to human gene therapy. To precisely modify target genes, homologous recombination must proceed with high fidelity. However, several results have suggested that targeted recombination may be highly mutagenic. To test the accuracy of gene targeting we analyzed 44 independent targeted recombinants at the hypoxanthine phosphoribosyltransferase (HPRT) locus in a human fibroblast cell line and in mouse embryonic stem cells. We surveyed 80 kilobases around the sites of recombination by using chemical cleavage of mismatches. Only two mutations were found: a T → G transversion and a thymidine deletion. Thus, gene targeting in mammalian cells can be extremely accurate. These results demonstrate the feasibility of generating precise modifications of mammalian genomes by gene targeting.

AB - Targeted recombination in murine embryonic stem cells promises to be a powerful tool for introducing specific mutations into target genes to study development in mice and to create animal models of human disease. Gene targeting also holds potential for correcting genetic defects as an approach to human gene therapy. To precisely modify target genes, homologous recombination must proceed with high fidelity. However, several results have suggested that targeted recombination may be highly mutagenic. To test the accuracy of gene targeting we analyzed 44 independent targeted recombinants at the hypoxanthine phosphoribosyltransferase (HPRT) locus in a human fibroblast cell line and in mouse embryonic stem cells. We surveyed 80 kilobases around the sites of recombination by using chemical cleavage of mismatches. Only two mutations were found: a T → G transversion and a thymidine deletion. Thus, gene targeting in mammalian cells can be extremely accurate. These results demonstrate the feasibility of generating precise modifications of mammalian genomes by gene targeting.

KW - Chemical cleavage

KW - Homologous recombination

KW - Hypoxanthine pbosphoribosyltransferase

KW - Mutation

UR - http://www.scopus.com/inward/record.url?scp=0025868463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025868463&partnerID=8YFLogxK

M3 - Article

C2 - 1896453

AN - SCOPUS:0025868463

VL - 88

SP - 8067

EP - 8071

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 18

ER -